Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

31 results about "Hypertrophic rhinitis" patented technology

Hypertrophic rhinitis that with thickening and swelling of the mucous membrane. membranous rhinitis chronic rhinitis with the formation of a false membrane, as in nasal diphtheria ; called also fibrinous rhinitis .

Oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine for treating various types of rhinitis

The invention relates to an oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine for treating various types of rhinitis, wherein the oral traditional Chinese medicine comprises more than 20 traditional Chinese medicines such as milkvetch root, manchurian wildginger herb, divaricate saposhnikovia, tall gastrodia rhizome, heartleaf houttuynia herb and the like, and the external application traditional Chinese medicine comprises more than 10 traditional Chinese medicines such as coptis chinensis, angelica archang lica, wasps nest, cow-bezoar, pearl powder and the like. According to the present invention, the medicine is the secret recipe inherited for six generations, and clinical improvement is performed for near several decades so as to provide significant treatment effects; clinical trial and treatment results of 560 acute rhinitis and chronic rhinitis patients in the local Chinese medicine hospitals, maternal and child health hospitals, and attached hospitals to medical colleges show that the total effective rate is 96% and a cure rate is 91%; and the oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine provides significant treatment effects for allergic rhinitis, chronic rhinitis, hypertrophic rhinitis, chronic sinusitis, paranasal sinusitis, nasal vestibulitis, atrophic rhinitis and turbinate hypertrophy, wherein the oral-external application combined treatment manner is adopted so as to achieve a symptom and root cause treatment effect.
Owner:张淯河

Traditional Chinese medicinal composition for treating rhinitis and preparing method thereof

InactiveCN107998207AEnsure ventilation and drainage functionNo side effectsAnthropod material medical ingredientsAerosol deliveryDiseaseNasal cavity
The invention belongs to the technical field of traditional Chinese medicinal preparations, and particularly relates to a traditional Chinese medicinal composition for treating rhinitis and a preparing method thereof. The traditional Chinese medicinal composition provided by the invention is prepared from 18 traditional Chinese medicines, wherein the 18 traditional Chinese medicines are totally divided into three groups; four medicinal materials of towel gourd stem, pedicellus melo, herba centipedae and a honeycomb are in one group, and have effects of mainly treating chronic rhinitis; seven medicinal materials of flos lonicerae, radix angelicae dahuricae, moschus, fructus xanthii, herba houttuyniae, flos magnoliae and herba menthae are in one group, and have effects of mainly treating simple and hypertrophic rhinitis; seven medicinal materials of poria cocos, fructus piperis longi, radix scutellariae, herba schizonepetae, rhizoma chuanxiong, bombyx batryticatus and catechu are in onegroup, and have effects of treating vasomotor rhinitis. The three groups of the medicinal materials are combined together to reach functions of fundamentally treating multiple kinds of rhinitis. The traditional Chinese medicinal composition provided by the invention uses removing a cause of a disease and guaranteeing ventilation and drainage functions of nasal cavities as a principle of treatment;the 18 traditional Chinese medicines are matched; a nasal mucosa can be effectively ameliorated; the rhinitis is treated; the traditional Chinese medicinal composition has no toxic and side effects on a human body, and can take effect within a short period; the dependence does not exist after a recovery, and the recrudescence does not exist or the recrudescence is seldom.
Owner:闫传涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products